Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study.
about
Preclinical development of AMG 139, a human antibody specifically targeting IL-23Efficacy and safety of secukinumab in the treatment of moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trialsIL-17RA in intestinal inflammation: structure, signaling, function, and clinical application.Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.Quantitative evaluation to efficacy and safety of therapies for psoriasis: A network meta-analysis.[Psoriatic arthritis : Drugs of the (near) future].
P2860
Q34795742-6A0DCA90-D6A3-40A5-ADD2-01D4737DE910Q35643453-64619413-4201-4D39-9C7A-96D59F3613FEQ38255855-86F3C517-1F8B-4788-8046-852D46A0927EQ38856226-1ECF4FBC-FD95-4618-B751-667E2FA6FAF0Q38858335-3ED1D201-D25B-439C-8FA3-E707CE98ACC2Q49963125-A19AC243-1B8B-4808-BEBD-DAC830570FF9Q54998108-54AC6945-6B77-461D-A299-9B7E3E75C113
P2860
Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Effects of briakinumab treatme ...... a randomized phase III study.
@en
Effects of briakinumab treatme ...... a randomized phase III study.
@nl
type
label
Effects of briakinumab treatme ...... a randomized phase III study.
@en
Effects of briakinumab treatme ...... a randomized phase III study.
@nl
prefLabel
Effects of briakinumab treatme ...... a randomized phase III study.
@en
Effects of briakinumab treatme ...... a randomized phase III study.
@nl
P2093
P2860
P356
P1476
Effects of briakinumab treatme ...... a randomized phase III study.
@en
P2093
D A Williams
J E Signorovitch
J M Valdes
M Sundaram
P M Mulani
P2860
P304
P356
10.1111/JDV.12177
P577
2013-05-17T00:00:00Z